Q1 2022 Holdings
Filed 2022-05-16 | 122 holdings | $414.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $11.6K | 437,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $12.2K | 830,472 | 0.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $13.8K | 1,229,234 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $14.1K | 249,988 | 0.0% |
| OAK STR Health Inc | NOTE 3/1 | 67181AAB3 | $14.3K | $18,000,000 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $14.7K | 2,078,692 | 0.0% |
| PTC Therapeutics Inc | NOTE 3.000% 8/1 | 69366JAB7 | $15.1K | $14,527,000 | 0.0% |
| Profound MED Corp(PROF) | COM NEW | 74319B502 | $15.4K | 1,713,797 | 0.0% |
| Da32 Life Scnce TEC Acqstn C | CLASS A COM | 23312M106 | $15.5K | 1,600,000 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $16.5K | 3,470,675 | 0.0% |
| Health Catalyst Inc | NOTE 2.500% 4/1 | 42225TAB3 | $17.2K | $15,000,000 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $18.2K | 400,622 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $18.8K | 3,577,233 | 0.0% |
| Goodrx Hldgs Inc(GDRX) | COM CL A | 38246G108 | $18.9K | 979,106 | 0.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $20.7K | 2,086,449 | 0.0% |
| Xeris Biopharma Holdings Inc | NOTE 5.000% 7/1 | 98422LAA5 | $21.1K | $18,000,000 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $21.4K | 369,514 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $22.2K | 270,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $22.7K | 891,587 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $23.6K | 5,830,249 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $25.3K | 3,672,808 | 0.0% |
| Novavax Inc | NOTE 3.750% 2/0 | 670002AB0 | $26.8K | $25,000,000 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $28.6K | 1,577,078 | 0.0% |
| The Oncology Institute Inc(TOI) | COM | 68236X100 | $32.1K | 3,296,107 | 0.0% |
| 1Life Healthcare Inc | NOTE 3.000% 6/1 | 68269GAB3 | $34.7K | $40,000,000 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $38.2K | 3,933,137 | 0.0% |
| Singular Genomics Systems in | COM | 82933R100 | $41.7K | 6,612,019 | 0.0% |
| Sema4 Holdings Corp(SMFRUSD) | COM CL A | 81663L101 | $42.5K | 13,848,488 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $42.7K | 4,695,020 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $45.0K | 134,989 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $45.5K | 765,489 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $47.4K | $80,000,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $48.9K | 465,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $51.7K | 5,580,456 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $53.0K | $57,791,000 | 0.0% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $64.4K | 8,456,876 | 0.0% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $65.4K | $61,000,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $71.0K | 4,416,361 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $72.3K | 3,282,912 | 0.0% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $74.9K | $75,000,000 | 0.0% |
| Nuvasive Inc | NOTE 0.375% 3/1 | 670704AJ4 | $76.1K | $80,000,000 | 0.0% |
| Insulet Corp | NOTE 0.375% 9/0 | 45784PAK7 | $76.2K | $57,581,000 | 0.0% |
| Tabula Rasa Healthcare Inc | NOTE 1.750% 2/1 | 873379AA9 | $79.7K | $107,816,000 | 0.0% |
| Apellis Pharmaceuticals Inc | NOTE 3.500% 9/1 | 03753UAB2 | $81.7K | $51,885,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $82.3K | 4,891,996 | 0.0% |
| Silk RD MED Inc | COM | 82710M100 | $88.9K | 2,153,712 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $91.7K | 3,695,341 | 0.0% |
| Nuvasive Inc | NOTE 1.000% 6/0 | 670704AL9 | $96.4K | $96,966,000 | 0.0% |
| Pacira Biosciences Inc | NOTE 0.750% 8/0 | 695127AF7 | $100.9K | $81,600,000 | 0.0% |
| Sarepta Therapeutics Inc | DBCV 1.500%11/1 | 803607AB6 | $116.1K | 88,657,000 | 0.0% |